Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018681 (
headache
)
56,091
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Blood plasma beta-endorphin concentrations were measured in 87 patients with various facial and
head pain
syndromes:
trigeminal neuralgia
or neuropathy Horner syndrome and migraine, facial autonomic pains. beta-endorphin concentrations were measured before and after treatment. In the groups under investigation, the neuropeptide showed opposite changes in plasma levels after the therapy depending on the type of the syndrome.
...
PMID:[Beta-endorphin levels in patients with pain syndromes in the areas of the face and head]. 253 37
The author indicates a dramatic rise in the number of patients with signs of dysfunction of the masticatory system which are one of the main social problems in modern stomatology. Including of dysfunction signs into the range of periodic stomatological examinations is postulated, and the principles of prevention of these disturbances are described. For the realisation of these aims it would be indicated to organize special scientific units, to introduce proper training of students and dentists as well as medical students, and to set up specialization in this branch of stomatology. In the treatment, especially in cases complicated with
headaches
and pain of the eyes, ears, spine and muscles in the vicinity, and with
trigeminal neuralgia
, a far reaching cooperation is needed of highly specialized stomatologists with the specialists from other branches of medicine.
...
PMID:[Justification of the needs and a trial of establishing of the principles of prophylaxis of functional disturbances in the stomatognathic system]. 264 Nov 61
The analgesic effects of lidocaine and tocainide on
trigeminal neuralgia
have been established. However, both drugs are unpractical: lidocaine can only be used intravenously, and tocainide may exhibit serious haematological side effects. Mexiletine, a structural analogue of lidocaine that can be safely administered by the oral route, was given, as the sole drug, to four patients with active
trigeminal neuralgia
. After at least seven days on mexiletine they had no clear benefit. The four patients subsequently improved with carbamazepine or phenytoin. Our observations suggest that mexiletine alone is not of value in
trigeminal neuralgia
.
Headache
1989 Sep
PMID:Failure of mexiletine to control trigeminal neuralgia. 279 56
Intracranial meningiomas account for 18.2% of all intracranial tumors. During Jan. 1982-Dec. 1986, 65 cases of intracranial meningiomas were diagnosed after operations and pathologic examinations at Taichung Veterans General Hospital. There were 36 females and 29 males, aged from 18 to 80 with a mean of 52 years. Average period of follow-up was 23.7 months. All patients received craniotomy or craniectomy with or without microscopic technique to remove the tumors & 3 cases received postoperative radiotherapy. The most common sites of meningiomas were the posterior fossa, convexity, parasagittal area and falx. The complete removal rate was 84.8%, the mortality rate 9.1% and the morbidity rate 33%. The major complications were intracerebral hemorrhage, infection of central nerve system, and hydrocephalus. There were 3 cases (4.6%) of multiple meningiomas. The most common symptoms and signs in order were
headache
, hemiparesis, seizure, nausea and vomiting, conscious disturbance &
trigeminal neuralgia
. The average duration of symptoms was 18.5 months. There were 9 cases of
trigeminal neuralgia
and 2 cases of hemifacial spasm. There were 3 cases (5.6%) of recurrence and 4 cases (6.1%) of malignancy. The most frequently found subtypes of meningiomas were the meningotheliomatous type and the transitional type. Mean size of the tumors was 5 cm. Tumor location and its biological behavior were closely related to the removal rate, prognosis and recurrence, while tumor size was of less importance. Ability of daily life was improved and seizure was better controlled by antiepileptic drugs in postoperative days.
...
PMID:[Intracranial meningiomas--5 year analysis]. 280 87
The treatment of
trigeminal neuralgia
by the minor percutaneous invasive procedures of selective thermal rhizotomy, glycerol injection, and balloon compression in the middle cranial fossa are compared with the open operations of compression in the middle fossa and MVD in the posterior fossa. A conservative end point for any one of the three percutaneous methods is recommended as the first invasive procedure in this disorder. The management of the facial pains in multiple sclerosis, cancer, posttraumatic and postherpetic pain, migrainous neuralgia (cluster
headache
), and vagoglossopharyngeal neuralgia is also discussed.
...
PMID:Percutaneous methods for the treatment of trigeminal neuralgia and other faciocephalic pain; comparison with microvascular decompression. 307 21
We report a case of bilateral intracavernous giant aneurysms of which the right side was clipped by direct surgery. Our case was a 74-year-old woman who developed bilateral abducens palsy. Computed tomography and angiography showed bilateral intracavernous giant aneurysms. This patient was followed up in the outpatient clinic. She developed
headache
and right
trigeminal neuralgia
2 years later. The trigeminal pain was quite severe and very disturbing to her. Repeat angiography showed an increase in the size of the aneurysms. An operation was carried out after a balloon Matus test monitoring electroencephalogram, somatosensory evoked potential, and clinical symptoms. The cavernous sinus was opened and the aneurysm was clipped. There was no postoperative complication except right ophthalmoplegia which resolved after 3 months.
Headache
and
trigeminal neuralgia
also disappeared.
...
PMID:Bilateral giant intracavernous aneurysms. Technique of unilateral operation. 333 38
Cluster headache is a rare
headache
entity that predominantly occurs in younger males. The clinical features are characterized by sudden attacks of unilateral excruciating pain localized periorbitally, associated with ipsilateral autonomic symptoms. The attacks occur in periods: clusters. The pathophysiology is still unknown. Such vasodilating substances as histamine, nitroglycerin and alcohol may provoke attacks. These substances may be used as diagnostic tests, but the interpretation of a negative result must be careful, as the attacks can not be induced in a refractory period after spontaneous occurrence, or at the beginning and end of cluster periods. As symptomatic treatment, ergotamine is the drug of first choice. High attack frequency may lead to overconsumption with ergotisme and further increased frequency. In such cases and for nocturnal attacks, oxygen inhalations represent an alternative. As prophylactic treatment ergotamine, methysergide, lithium and prednisone have proved efficacious. Most patients benefit from such treatment and may become virtually free from attacks. It is, therefore, important to differentiate this
headache
entity from classical migraine, common migraine and
trigeminal neuralgia
.
...
PMID:Cluster headache: a review. 353 83
In a double-blind study the efficacy and tolerability of tizanidine was compared with those of carbamazepine in the management of
trigeminal neuralgia
. Six patients were allocated to treatment with tizanidine and six to carbamazepine. After individual titration the maximum daily doses were 18 mg and 900 mg, respectively. Among the efficacy factors used, the visual analog scale (VAS) and the overall efficacy as assessed by patients and investigator turned out to be the most appropriate. The results indicate that tizanidine was well tolerated, but the effects, if any, were inferior to those of carbamazepine.
Cephalalgia
1986 Sep
PMID:Tizanidine in the management of trigeminal neuralgia. 353 72
A case of cluster-tic syndrome is presented. A 51-year-old man developed pain attacks corresponding to the second branch of the trigeminal nerve. After treatment with 1200 mg carbamazepine daily, the attacks disappeared. Full remission was achieved, and carbamazepine therapy was continued. Pain attacks of a quite different character then appeared; their clinical picture corresponded to cluster
headache
. After treatment with cyproheptadine, the cluster
headache
attacks ceased, but 2 days later, before the discontinuation of the treatment, the attacks of
trigeminal neuralgia
reappeared. Treatment with carbamazepine was started again, and there was remission of the
trigeminal neuralgia
after several weeks.
Cephalalgia
1987 Jun
PMID:Cluster-tic syndrome. 360 69
The author describes a case with elements of
trigeminal neuralgia
coexistent with Horton's
headaches
, with predominance of the latter ones. For this syndrome the author proposes the name "cluster-tic". In the pathogenesis of
headache
attacks of Horton's type and neuralgia of the V nerve the mediation of neurotransmitters and the nosological position of the described syndrome are discussed.
...
PMID:["Cluster-tic syndrome" with a report of our case]. 365 99
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>